01-01-1970 12:00 AM | Source: Reuters
India's Serum Institute takes 50% stake in drug vial maker Schott Kaisha
BENGALURU - Serum Institute of India, the world's largest vaccine maker by production volume, has taken a 50% stake in Indian drug vial maker Schott Kaisha, the companies said in a statement https://bit.ly/3AIBLvS on Tuesday.
Serum Institute was already a customer of Schott Kaisha, using their vials, ampoules and syringes to store vaccines including the COVID-19 vaccine Covishield. The companies did not provide any further details on the deal.
Latest News
Nail Fashion Trends: The Art of Expressing Style Thr...
Sustainable Living: Tips for a Greener Lifestyle
PM Narendra Modi to attend Christmas celebrations ho...
Government launching 3 apps to protect consumers in ...
Kia to launch compact SUV `Syros` in India next year
GST recommendations to create business-friendly envi...
CII seeks priority sector lending for new and emergi...
The Wealth of Experiences: How Travel and Cultural E...
India`s tax panel rejects airlines` call to add avia...
Rozgar Mela: PM Narendra Modi to distribute 71,000 a...